A 12-week study to assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants with Inadequately Controlled Asthma (LITHOS)

Trial Identifier: D5982C00005
Sponsor: AstraZeneca
NCTID:: NCT05755906
Start Date: February 2023
Primary Completion Date: January 2025
Study Completion Date: January 2025
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations